These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36465380)

  • 1. Impact of SOX2 function and regulation on therapy resistance in bladder cancer.
    Chen G; Chen Y; Xu R; Zhang G; Zou X; Wu G
    Front Oncol; 2022; 12():1020675. PubMed ID: 36465380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells.
    Jin ML; Yang L; Jeong KW
    Theranostics; 2022; 12(13):5761-5775. PubMed ID: 35966598
    [No Abstract]   [Full Text] [Related]  

  • 3. Long Noncoding RNA
    Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
    Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation.
    Xie Q; Hua X; Huang C; Liao X; Tian Z; Xu J; Zhao Y; Jiang G; Huang H; Huang C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of sex-determining region Y-box 2 in cell pluripotency and tumor-related signaling pathways.
    Wang J; Zeng H; Li H; Zhang J; Wang S
    Mol Clin Oncol; 2015 Nov; 3(6):1203-1207. PubMed ID: 26807221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor sex-determining region Y-box 2 (SOX2) in bladder cancer.
    Griffin RL; Shuman L; Yamashita H; Wu Q; Chen G; Brown RM; Vander Griend D; DeGraff DJ; Warrick JI
    Am J Clin Exp Urol; 2024; 12(2):88-99. PubMed ID: 38736621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.
    Bellmunt J
    Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30072631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
    Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
    J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.
    Wang J; Zeng H; Li H; Chen T; Wang L; Zhang K; Chen J; Wang R; Li Q; Wang S
    Cell Physiol Biochem; 2017; 43(2):717-732. PubMed ID: 28946143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings.
    Wang T; Yang Y; Wang Z; Zhang X; Li D; Wei J
    J Cell Mol Med; 2020 Aug; 24(15):8545-8556. PubMed ID: 32596945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of the Hippo-YAP pathway in bladder cancer.
    Cheng X; Lou K; Ding L; Zou X; Huang R; Xu G; Zou J; Zhang G
    Front Oncol; 2022; 12():925278. PubMed ID: 35912245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
    Ferreira-Teixeira M; Parada B; Rodrigues-Santos P; Alves V; Ramalho JS; Caramelo F; Sousa V; Reis F; Gomes CM
    Oncotarget; 2015 Nov; 6(34):36185-201. PubMed ID: 26452033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
    Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
    Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
    Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives.
    Ohishi T; Koga F; Migita T
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel tumor suppressing gene,
    Piao XM; Jeong P; Yan C; Kim YH; Byun YJ; Xu Y; Kang HW; Seo SP; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Oncol Lett; 2020 Jan; 19(1):476-486. PubMed ID: 31897161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
    Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
    Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
    Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.